Final Results of the IFCT-0803 Study, a Phase II Study of Cetuximab, Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced, Unresectable, Stage III, Non-Squamous, Non-Small-cell Lung Cancer.
Cancer/Radiothérapie(2022)
Key words
Stage III NSCLC,Concurrent chemoradiotherapy,Cetuximab,Pemetrexed,Cisplatin
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined